The plaintiff challenges price transparency regulations requiring health insurers to disclose prescription drug pricing data in a machine-readable format—arguing that such requirements violate the Administrative Procedure Act. Broad health care transparency and disclosure measures can help facilitate more informed health care decisions for consumers, promote higher value care, and potentially lower health care prices.
Potential Impact:
Preventing the federal government from crafting price transparency regulations and promoting greater public disclosure could lead to consumers losing a valuable tool to make informed decisions and potentially face higher health care prices.
Administrative Procedure Act - Contrary to Law, Administrative Procedure Act - Notice and Comment Violation, Administrative Procedure Act - Arbitrary and Capricious
Litigation Metadata
Date Filed
August 12, 2021
Case Type
Civil
Court Type
District Court
Court
District of Columbia
Judge
Bates, John D. Appointed By: George W. Bush
Plaintiff(s)
Pharmaceutical Care Management Association
Lead Counsel For Plaintiff(s)
Gibson, Dunn & Crutcher LLP
Defendant(s)
Department of Health and Human Services; Centers for Medicare & Medicaid Services; Department of the Treasury; Internal Revenue Service; Department of Labor; Employee Benefits Security Administration, Xavier Becerra; Chiquita Brooks-LaSure; Janet Yellen; Douglas O'Donnell; Martin J. Walsh; Ali Khawar
Pharmaceutical Care Management Association v. Department of Health and Human Services et al.
Goal
Issues
Litigation Content
Potential Impact:
Why this Matters:
The plaintiff challenges price transparency regulations requiring health insurers to disclose prescription drug pricing data in a machine-readable format—arguing that such requirements violate the Administrative Procedure Act. Broad health care transparency and disclosure measures can help facilitate more informed health care decisions for consumers, promote higher value care, and potentially lower health care prices.
Potential Impact:
Preventing the federal government from crafting price transparency regulations and promoting greater public disclosure could lead to consumers losing a valuable tool to make informed decisions and potentially face higher health care prices.
3 Major Filings
Related Litigation
Litigation Information
Current Status
Case dismissed
Legal Issues
Administrative Procedure Act - Contrary to Law, Administrative Procedure Act - Notice and Comment Violation, Administrative Procedure Act - Arbitrary and Capricious
Litigation Metadata